NCT00390689 - A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2008

Conditions

Idiopathic Restless Legs Syndrome

Interventions

DRUG

Pramipexole 0.125 mg tablet

DRUG

Pramipexole 0.5 mg tablet

Trial Locations (34)

Unknown

248.627.037 Boehringer Ingelheim Investigational Site, Aichi-gun, Aichi

248.627.014 Boehringer Ingelheim Investigational Site, Fujisawa, Kanagawa

248.627.029 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

248.627.032 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

248.627.030 Boehringer Ingelheim Investigational Site, Kagoshima, Kagoshima

248.627.013 Boehringer Ingelheim Investigational Site, Kanagawa, Yokohama

248.627.033 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa

248.627.027 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

248.627.023 Boehringer Ingelheim Investigational Site, Kitakyusyu, Fukuoka

248.627.024 Boehringer Ingelheim Investigational Site, Kitakyusyu, Fukuoka

248.627.022 Boehringer Ingelheim Investigational Site, Kochi, Kochi

248.627.034 Boehringer Ingelheim Investigational Site, Kodaira, Tokyo

248.627.038 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

248.627.041 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

248.627.039 Boehringer Ingelheim Investigational Site, Kumamoto, Kumamoto

248.627.003 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka

248.627.036 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

248.627.025 Boehringer Ingelheim Investigational Site, Mitaka-shi, Tokyo

248.627.015 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

248.627.017 Boehringer Ingelheim Investigational Site, Osaka, Osaka

248.627.011 Boehringer Ingelheim Investigational Site, Otaru, Hokkaido

248.627.026 Boehringer Ingelheim Investigational Site, Otsu, Shiga

248.627.002 Boehringer Ingelheim Investigational Site, Sakai,Osaka

248.627.010 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

248.627.035 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

248.627.012 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

248.627.001 Boehringer Ingelheim Investigational Site, Shibuya-ku, Tokyo

248.627.004 Boehringer Ingelheim Investigational Site, Shimotsuga-gun,Tochigi

248.627.040 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

248.627.018 Boehringer Ingelheim Investigational Site, Takatsuki,Osaka

248.627.028 Boehringer Ingelheim Investigational Site, Tokorozawa, Saitama

248.627.019 Boehringer Ingelheim Investigational Site, Tokushima, Tokushima

248.627.016 Boehringer Ingelheim Investigational Site, Toyohashi, Aichi

248.627.031 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa